Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Quinn
AddedMar 20, 2024
UpdatedJul 4, 2026
Quinn

Quinn

Pre-Seed

iollo offers an AI-guided, at-home metabolomics test that analyzes 500+ blood biomarkers to deliver personalized health and aging insights.

HQ
San Francisco, CA, US
Founded
2022
Accelerator
Y Combinator logoY CombinatorS22
Overview
Analysis
Compare
Fundraising
Employees
News
Website

iollo is a San Francisco-based wellness company that offers an at-home metabolomics test analyzing more than 500 blood biomarkers. Users collect a finger-stick sample with a CE-marked device, return it by mail, and receive reports on biological age, metabolic health, heart health, liver health, immune health, digestive health, and other wellness domains. Machine-learning models compare results against a curated research database and the user's longitudinal data to generate evidence-based recommendations for diet, exercise, supplements, and lifestyle.

Founded in 2022 by Daniel Gomari, Jan Krumsiek, and Brent LaRue, with scientific co-founder Michael Snyder, iollo participated in Y Combinator's Summer 2022 batch. The company is backed by scientists from Stanford and Cornell with deep experience in metabolomics and computational biology. Its service is positioned for wellness and prevention rather than clinical diagnosis, and integrates with wearables and other lab results to help users track how changes affect their biomarkers over time.

Quinn - Products & Services

  • At-home metabolomics health test logo

    At-home metabolomics health test

    iollo's at-home metabolomics test measures 500+ blood biomarkers to generate personalized health and aging insights.

    Competing Products

    Viome logo
    InsideTracker logo

Quinn - Similar Companies

Viome logo

Viome

viome.com

InsideTracker logo

InsideTracker

insidetracker.com

Superpower logo

Superpower

superpower.com

Function Health logo

Function Health

functionhealth.com

Instalab logo

Instalab

instalab.com

Lab Me Analytics logo

Lab Me Analytics

labme.ai

AssayMe logo

AssayMe

assayme.cc

Everly Well logo

Everly Well

Elo Health logo

Elo Health

elo.health

AgoraLV logo

AgoraLV

Generation Lab logo

Generation Lab

generationlab.co

Pnoē logo

Pnoē

pnoe.com

Jona logo

Jona

jona.health

Fitnescity logo

Fitnescity

fitnescity.com

neuroLytixs logo

neuroLytixs

neurolytixs.com

Quinn - Quick Facts

Who are Quinn's competitors?

Companies similar to Quinn include Viome, InsideTracker, Superpower and Function Health.

When was Quinn founded?

Quinn was founded in 2022.

Where is Quinn's headquarters located?

Quinn's headquarters is located in San Francisco, CA, US.

When was Quinn's last funding round?

Quinn's most recent funding round was for $500k (USD) in August 2022.

How much has Quinn raised to-date?

As of Aug 22, 2022, Quinn has raised a total of $1M (USD).

How many employees does Quinn have?

Quinn has 3 employees as of Apr 25, 2024.

Quinn - Classification

Industry
  • Biotechnology
  • Healthcare
Ownership
  • Venture Capital
Technology
  • AI
  • Analytics
  • Bioinformatics
  • Machine Learning
  • Mass Spectrometry
Geographic Exposure
  • Global
Model
  • B2C Subscription
  • Direct
Revenue
  • Subscription
  • Transactional
Customer
  • Consumers
Tags
  • Biotech
  • Data Information
  • eCommerce
  • Healthtech
  • Health Testing